Safety profile of infliximab in inflammatory bowel disease: Single-center experience in 102 patients and 672 infusions

Autor:	Silvio Danese, Alessandro Gasbarrini, Luisa Guidi, Giuseppe Fedeli, A. Papa, Andrea Lupascu, Domenico Melina, G. Gasbarrini, P. Fedeli, I. De Vitis, I. Roberto, Maria Chiara Mentella, B. De Pascalis, A. Armuzzi
Rok vydání:	2006
Předmět:	medicine.medical_specialty Hepatology business.industry Gastroenterology medicine.disease Single Center Inflammatory bowel disease Infliximab Safety profile Internal medicine medicine business medicine.drug
Zdroj:	Digestive and Liver Disease. 38:S14-S15
ISSN:	1590-8658
DOI:	10.1016/s1590-8658(06)80035-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b193f8f125d9b905529656997e25799d https://doi.org/10.1016/s1590-8658(06)80035-6 Zobrazit plný text záznamu Full Text from ScienceDirect